Expression of neuroendocrine markers in meningeal and extrameningeal solitary fibrous tumors: a potential diagnostic pitfall
Authors:
- 9 May 2023
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 137, 79-84
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?Human Pathology, 2020
- Solitary fibrous tumor: a case series identifying pathological adverse factors—implications for risk stratification and classificationVirchows Archiv, 2019
- Recent Progress in the Pathology and Genetics of Pilocytic and Pilomyxoid AstrocytomasBalkan Medical Journal, 2019
- High p16 Expression Is Associated with Malignancy and Shorter Disease-Free Survival Time in Solitary Fibrous Tumor/HemangiopericytomaJournal of Neurological Surgery Part B: Skull Base, 2018
- INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcomaLaboratory Investigation, 2018
- Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification modelLaboratory Investigation, 2017
- Immunohistochemical Approach to the Differential Diagnosis of Meningiomas and Their MimicsJournal of Neuropathology & Experimental Neurology, 2017
- STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimicsPathology, 2014
- Expression of diagnostic neuronal markers and outcome in glioblastomaNeuropathology and Applied Neurobiology, 2010
- Malignant Peripheral Nerve Sheath TumorAmerican Journal of Surgical Pathology, 2003